Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer.
about
Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancerCirculating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer.Changes of Microrna Levels in Plasma of Patients with Rectal Cancer during Chemoradiotherapy.Multidisciplinary treatment of rectal cancer in 2014: where are we going?Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patientsIncreased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer.A multicentric randomized controlled trial on the impact of lengthening the interval between neoadjuvant radiochemotherapy and surgery on complete pathological response in rectal cancer (GRECCAR-6 trial): rationale and design.Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trialThe association of age and race and the risk of large bowel polyps.Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapyCan an IL13 -1112 C/T (rs1800925) polymorphism predict responsiveness to neoadjuvant chemoradiotherapy and survival of Chinese Han patients with locally advanced rectal cancer?Clinical parameters predicting pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer.Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.Pathological correlation with diffusion restriction on diffusion-weighted imaging in patients with pathological complete response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary resultsPredictors of Complete Response and Disease Recurrence Following Chemoradiation for Rectal Cancer.Clinical predictive factors of pathologic tumor response after preoperative chemoradiotherapy in rectal cancerSurgical issues in locally advanced rectal cancer treated by preoperative chemoradiotherapy.New tumor regression grade for rectal cancer after neoadjuvant therapy and radical surgery.Racial disparities in advanced-stage colorectal cancer survivalUtility of rectoscopy in the assessment of response to neoadjuvant treatment for locally advanced rectal cancer.Does Delaying Surgical Resection After Neoadjuvant Chemoradiation Impact Clinical Outcomes in Locally Advanced Rectal Adenocarcinoma?: A Single-Institution Experience.A novel histologic grading scheme based on poorly differentiated clusters is applicable to treated rectal cancer and is associated with established histopathological prognosticators.Lymph nodes regression grade is a predictive marker for rectal cancer after neoadjuvant therapy and radical surgery.Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapyPredictive factors of the response of rectal cancer to neoadjuvant radiochemotherapy.Clinical factors of post-chemoradiotherapy as valuable indicators for pathological complete response in locally advanced rectal cancerAn observational study of extending FOLFOX chemotherapy, lengthening the interval between radiotherapy and surgery, and enhancing pathological complete response rates in rectal cancer patients following preoperative chemoradiotherapy.Treatment Interval between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer Patients: A Population-Based Study.Extended Intervals after Neoadjuvant Therapy in Locally Advanced Rectal Cancer: The Key to Improved Tumor Response and Potential Organ Preservation.Delaying surgery after neoadjuvant chemoradiotherapy improves prognosis of rectal cancer.Does Extending the Waiting Time of Low-Rectal Cancer Surgery after Neoadjuvant Chemoradiation Increase the Perioperative Complications?Pathological Assessment of Rectal Cancer after Neoadjuvant Chemoradiotherapy: Distribution of Residual Cancer Cells and Accuracy of Biopsy.Clinical predictive factors of pathologic complete response in locally advanced rectal cancer.Results of intraoperative electron beam radiotherapy containing multimodality treatment for locally unresectable T4 rectal cancer: a pooled analysis of the Mayo Clinic Rochester and Catharina Hospital EindhovenPredictors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer.Interval to surgery after neoadjuvant treatment for colorectal cancer.Racial Differences in Stage IV Colorectal Cancer Survival in Younger and Older Patients.Increased tumor response to neoadjuvant therapy among rectal cancer patients taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy.
P2860
Q26796352-FFB204B7-4549-4F3D-91B4-06332354598BQ33816412-DCB195F9-53F3-49EF-815A-8E0847B7F688Q33838484-0044D01B-ED63-432A-9290-C4BA3479C3E8Q34093825-0B4590A0-B875-4F52-ACAC-97225D6CD457Q34787505-4D012884-BC7B-499C-B6CE-58014786E224Q34836622-20787C9A-0131-4F6C-92F4-35222E6BDE19Q34985904-A3A81C6B-F10E-47E1-93A8-C0184836C5CEQ35046474-AD7E4A29-3E83-4DC8-B57F-746E5CBC09F1Q35805542-9B3F9CFE-13C0-4BF0-B9CA-5AD3ED6D836BQ35814400-1E84FCF8-9CDB-4C10-A275-9BB8046DC594Q36014263-42086F70-3ACD-4786-87FB-4753D4F7BE24Q36121224-6A3EE820-9B54-4F7B-BE7E-1631FB43563FQ36348179-E8FC7335-06DB-4CE9-8BE4-2636025A959CQ36365456-9F98B1BB-FE3D-4743-812B-0EF9C2CF6993Q36392034-CDA095B3-67AE-4DCC-A592-440D7D70418BQ36395269-C6CA8646-8836-418C-AB78-73109D39269DQ36514882-0D604D42-8FBF-4ED2-B5B0-E8D3E8BF8CB5Q36561726-1A8EE3EF-8C35-4CE2-8C55-4458F600BD0AQ36614943-C15901E1-BEAA-4EDB-B627-1A48A4893AF4Q36755456-038FBD30-0D62-4981-93A4-71931E57B2CFQ36880544-06C9C88A-F21D-4802-AB70-5A7B426BA8E0Q36903261-6976EF7B-12B3-4FCF-8DA1-EA6C3FC56545Q37086177-CFBBBE33-9B31-4388-A9E9-C9147A739B51Q37106318-6D3FB424-B3BB-429C-B83A-0584A02B236EQ37132742-827882B7-EE11-4B50-9584-6FCCAFB7D978Q37156190-8366C7A3-7093-4ECE-A39E-B29306DD61AAQ37173767-FBD2D690-9521-446F-86DF-B4939109C406Q37227461-7679C345-D240-4C63-9710-E67C48DF5603Q37238569-74562228-7E1C-422C-A676-43AF414752FDQ37263114-D8DC9CFD-99A6-4C13-B054-2EA7D755F38EQ37322728-3D794666-737A-49DB-B8D7-BFA0BE7EF2BAQ37323833-1B1A0311-8B23-46BC-919F-19D7F578B8FBQ37362938-11320E39-C0FD-42C5-8714-409DF5A9EEC2Q37525377-E0084FC4-9CF9-42B0-87AF-3CD6269E8A81Q37628506-A0C1E8B8-64EA-4C18-ACB7-F0DBF4BF994CQ37729169-938ECF0D-E230-4330-B097-CCD9521B920CQ38207015-1EA63641-0178-4D5E-AA8A-242B691A034EQ38773304-1B638D0F-EC91-4E3D-997A-E6F54DE3AA7FQ39749935-47898AE1-82C0-463F-A488-1B851C664C0DQ39884524-92E04877-F5A1-453D-95AE-8FDA47262352
P2860
Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Predictive factors of patholog ...... moradiation for rectal cancer.
@en
Predictive factors of patholog ...... moradiation for rectal cancer.
@nl
type
label
Predictive factors of patholog ...... moradiation for rectal cancer.
@en
Predictive factors of patholog ...... moradiation for rectal cancer.
@nl
prefLabel
Predictive factors of patholog ...... moradiation for rectal cancer.
@en
Predictive factors of patholog ...... moradiation for rectal cancer.
@nl
P2093
P1433
P1476
Predictive factors of patholog ...... moradiation for rectal cancer.
@en
P2093
Daniel P Geisler
David Dietz
Ian C Lavery
Luca Stocchi
Luiz Felipe de Campos-Lobato
Matthew F Kalady
Victor W Fazio
P304
P356
10.1097/SLA.0B013E3181B91E63
P407
P577
2009-10-01T00:00:00Z